-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on RXO, Raises Price Target to $30

Benzinga·10/06/2026 18:05:31
Listen to the news
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $23 to $30.